Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson & Johnson company gets rights to Closure wound product:

This article was originally published in Clinica

Executive Summary

Closure Medical has granted Johnson & Johnson Wound Management worldwide supply, distribution and development rights to its professional wound management platform, including its Liquid Occlusive Dressing (LOD). J&J Wound Management, part of the Ethicon division, has rights to the products for the management and treatment of partial-thickness wounds. Raleigh, North Carolina-based Closure plans to submit a 510(k) to the FDA for the LOD product in mid-2002. The company estimates the global advanced wound management market to be worth around $1 billion.

Topics

UsernamePublicRestriction

Register

MT074050

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel